
GoodRx raises more than $1B in IPO
GoodRx began trading on Nasdaq in an upsized IPO. The company priced its stock at $33 per share, up from its expected range of $24 to $28 per share.
GoodRx began trading on Nasdaq in an upsized IPO. The company priced its stock at $33 per share, up from its expected range of $24 to $28 per share.
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.
GoodRx, a digital health startup that helps users track prescription drug prices, filed for an IPO on Friday. The company hasn't yet priced its shares, but plans to be listed on Nasdaq as "GDRX."
GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The company reportedly submitted paperwork to the Securities and Exchange Commission.
The spun off company will be renamed Capsule Technologies and will continue to operate as two separate business entities: Capsule and 2net.
GoodRx, for example, developed a skill for Amazon's Alexa to track down cheap prescription drugs.